Richard Paul Bryce - Net Worth and Insider Trading

Richard Paul Bryce Net Worth

The estimated net worth of Richard Paul Bryce is at least $601,010 dollars as of 2024-05-15. Richard Paul Bryce is the SEE REMARKS of Puma Biotechnology Inc and owns about 121,662 shares of Puma Biotechnology Inc (PBYI) stock worth over $601,010. Details can be seen in Richard Paul Bryce's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard Paul Bryce has not made any transactions after 2021-04-05 and currently still holds the listed stock(s).

Transaction Summary of Richard Paul Bryce

To

Richard Paul Bryce Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Paul Bryce owns 3 companies in total, including Puma Biotechnology Inc (PBYI) , Rain Oncology Inc (RAIN) , and enGene Holdings Inc (ENGN) .

Click here to see the complete history of Richard Paul Bryce’s form 4 insider trades.

Insider Ownership Summary of Richard Paul Bryce

Ticker Comapny Transaction Date Type of Owner
PBYI Puma Biotechnology Inc 2021-04-05 SR VP & CLINICAL RESEARCH & DEV
RAIN Rain Oncology Inc 2021-04-22 Chief Medical Officer
ENGN enGene Holdings Inc 2023-10-31 Chief Medical Officer

Richard Paul Bryce Latest Holdings Summary

Richard Paul Bryce currently owns a total of 1 stock. Richard Paul Bryce owns 121,662 shares of Puma Biotechnology Inc (PBYI) as of April 5, 2021, with a value of $601,010.

Latest Holdings of Richard Paul Bryce

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PBYI Puma Biotechnology Inc 2021-04-05 121,662 4.94 601,010

Holding Weightings of Richard Paul Bryce


Richard Paul Bryce Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Paul Bryce has made a total of 24 transactions in Puma Biotechnology Inc (PBYI) over the past 5 years, including 0 buys and 24 sells. The most-recent trade in Puma Biotechnology Inc is the sale of 426 shares on April 5, 2021, which brought Richard Paul Bryce around $4,175.

Insider Trading History of Richard Paul Bryce

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Paul Bryce Trading Performance

GuruFocus tracks the stock performance after each of Richard Paul Bryce's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Paul Bryce is -14.09%. GuruFocus also compares Richard Paul Bryce's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Paul Bryce within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Richard Paul Bryce's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Richard Paul Bryce

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.89
Relative Return to S&P 500(%) -12.35

Richard Paul Bryce Ownership Network

Ownership Network List of Richard Paul Bryce

No Data

Ownership Network Relation of Richard Paul Bryce


Richard Paul Bryce Owned Company Details

What does Puma Biotechnology Inc do?

Who are the key executives at Puma Biotechnology Inc?

Richard Paul Bryce is the SR VP & CLINICAL RESEARCH & DEV of Puma Biotechnology Inc. Other key executives at Puma Biotechnology Inc include Chief Commercial Officer Jeffrey Jerome Ludwig , Chief Scientific Officer Alvin F Wong , and Chief Financial Officer Maximo F Nougues .

Puma Biotechnology Inc (PBYI) Insider Trades Summary

Over the past 18 months, Richard Paul Bryce made no insider transaction in Puma Biotechnology Inc (PBYI). Other recent insider transactions involving Puma Biotechnology Inc (PBYI) include a net sale of 19,194 shares made by Alvin F Wong , a net sale of 130,586 shares made by Alan H Auerbach , and a net sale of 41,020 shares made by Maximo F Nougues .

In summary, during the past 3 months, insiders sold 0 shares of Puma Biotechnology Inc (PBYI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 377,648 shares of Puma Biotechnology Inc (PBYI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,648 shares.

Puma Biotechnology Inc (PBYI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Puma Biotechnology Inc Insider Transactions

No Available Data

Richard Paul Bryce Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Paul Bryce. You might contact Richard Paul Bryce via mailing address: C/o Puma Biotechnology, Inc., 10880 Wilshire Boulevard, Suite 2150, Los Angeles Ca 90024.

Discussions on Richard Paul Bryce

No discussions yet.